Reuters logo
BRIEF-VBI Vaccines completes pre-IND meeting for its Glioblastoma Immunotherapy Candidate
October 11, 2016 / 1:06 PM / a year ago

BRIEF-VBI Vaccines completes pre-IND meeting for its Glioblastoma Immunotherapy Candidate

Oct 11 (Reuters) - VBI Vaccines Inc

* VBI Vaccines completes pre-ind meeting for its glioblastoma immunotherapy candidate

* VBI Vaccines Inc - VBI anticipates filing ind for VBI-1901 in first half of 2017

* VBI Vaccines Inc - FDA will consider a fast track designation for VBI-1901 at time of IND submission Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below